SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-002775
Filing Date
2024-05-13
Accepted
2024-05-13 16:24:17
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1128906
2 AMENDED AND RESTATED BYLAWS, AS AMENDED vnrx_ex32.htm EX-3.2 207896
3 CERTIFICATION vnrx_ex311.htm EX-31.1 13125
4 CERTIFICATION vnrx_ex312.htm EX-31.2 12888
5 CERTIFICATION vnrx_ex321.htm EX-32.1 6589
  Complete submission text file 0001477932-24-002775.txt   6236041

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20240331.xsd EX-101.SCH 76513
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20240331_lab.xml EX-101.LAB 363769
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20240331_cal.xml EX-101.CAL 52854
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20240331_pre.xml EX-101.PRE 325458
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20240331_def.xml EX-101.DEF 218768
77 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 1025166
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 24939423
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)